2.50
Hdl Handle:
http://hdl.handle.net/10033/269012
Title:
Comparison of in vitro and in vivo protein release from hydrogel systems.
Authors:
Wöhl-Bruhn, Stefanie; Badar, Muhammad; Bertz, Andreas; Tiersch, Brigitte; Koetz, Joachim; Menzel, Henning; Mueller, Peter P; Bunjes, Heike
Abstract:
Hydrogel systems based on hydroxyethyl starch-polyethylene glycol methacrylate (HES-P(EG)(6)MA) or hydroxyethyl starch methacrylate (HES-MA) were used to assess the protein release behavior. Here, we analyzed the in vitro release of FITC-anti-human antibodies incorporated in either HES-P(EG)(6)MA or HES-MA hydrogel delivery systems in PBS or human serum. In addition, hydrogel disks and microparticles prepared from the two polymers were subcutaneously implanted in BALB/c mice. The in vivo release of FITC-IgG was non-invasively monitored by an in vivo imaging system (IVIS 200) over a time period of up to 3 months. The imaging system allowed to asses individual animals over time, therefore only a small number of animals was required to obtain high quality data. The reduction in fluorescence intensity at the site of administration was compared to in vitro release profiles. These investigations demonstrated a sustained release from HES-MA hydrogel disks compared to rapidly degrading HES-P(EG)(6)MA disks and microparticles. The sustained release from HES-MA disks could be further optimized by using increased polymer concentrations. Human serum as in vitro release medium reflected better the in vivo release from HES-P(EG)(6)MA systems than PBS, suggesting that the presence of organic substances like proteins or lipids may play a significant role for the release kinetics.
Affiliation:
Technische Universität Braunschweig, Institute of Pharmaceutical Technology, Mendelssohnstraße 1, 38106 Braunschweig, Germany.
Citation:
Comparison of in vitro and in vivo protein release from hydrogel systems. 2012, 162 (1):127-33 J Control Release
Journal:
Journal of controlled release : official journal of the Controlled Release Society
Issue Date:
20-Aug-2012
URI:
http://hdl.handle.net/10033/269012
DOI:
10.1016/j.jconrel.2012.05.049
PubMed ID:
22687287
Type:
Article
Language:
en
ISSN:
1873-4995
Appears in Collections:
Publications of Dept. Gene Regulation and Differentiation (RDIF)

Full metadata record

DC FieldValue Language
dc.contributor.authorWöhl-Bruhn, Stefanieen_GB
dc.contributor.authorBadar, Muhammaden_GB
dc.contributor.authorBertz, Andreasen_GB
dc.contributor.authorTiersch, Brigitteen_GB
dc.contributor.authorKoetz, Joachimen_GB
dc.contributor.authorMenzel, Henningen_GB
dc.contributor.authorMueller, Peter Pen_GB
dc.contributor.authorBunjes, Heikeen_GB
dc.date.accessioned2013-02-11T14:43:02Z-
dc.date.available2013-02-11T14:43:02Z-
dc.date.issued2012-08-20-
dc.identifier.citationComparison of in vitro and in vivo protein release from hydrogel systems. 2012, 162 (1):127-33 J Control Releaseen_GB
dc.identifier.issn1873-4995-
dc.identifier.pmid22687287-
dc.identifier.doi10.1016/j.jconrel.2012.05.049-
dc.identifier.urihttp://hdl.handle.net/10033/269012-
dc.description.abstractHydrogel systems based on hydroxyethyl starch-polyethylene glycol methacrylate (HES-P(EG)(6)MA) or hydroxyethyl starch methacrylate (HES-MA) were used to assess the protein release behavior. Here, we analyzed the in vitro release of FITC-anti-human antibodies incorporated in either HES-P(EG)(6)MA or HES-MA hydrogel delivery systems in PBS or human serum. In addition, hydrogel disks and microparticles prepared from the two polymers were subcutaneously implanted in BALB/c mice. The in vivo release of FITC-IgG was non-invasively monitored by an in vivo imaging system (IVIS 200) over a time period of up to 3 months. The imaging system allowed to asses individual animals over time, therefore only a small number of animals was required to obtain high quality data. The reduction in fluorescence intensity at the site of administration was compared to in vitro release profiles. These investigations demonstrated a sustained release from HES-MA hydrogel disks compared to rapidly degrading HES-P(EG)(6)MA disks and microparticles. The sustained release from HES-MA disks could be further optimized by using increased polymer concentrations. Human serum as in vitro release medium reflected better the in vivo release from HES-P(EG)(6)MA systems than PBS, suggesting that the presence of organic substances like proteins or lipids may play a significant role for the release kinetics.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Journal of controlled release : official journal of the Controlled Release Societyen_GB
dc.subject.meshAbsorbable Implantsen_GB
dc.subject.meshAnimalsen_GB
dc.subject.meshDrug Delivery Systemsen_GB
dc.subject.meshFluorescein-5-isothiocyanateen_GB
dc.subject.meshGoatsen_GB
dc.subject.meshHetastarchen_GB
dc.subject.meshHumansen_GB
dc.subject.meshHydrogelen_GB
dc.subject.meshImmunoglobulin Gen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMethacrylatesen_GB
dc.subject.meshMiceen_GB
dc.subject.meshMice, Inbred BALB Cen_GB
dc.subject.meshPolyethylene Glycolsen_GB
dc.titleComparison of in vitro and in vivo protein release from hydrogel systems.en
dc.typeArticleen
dc.contributor.departmentTechnische Universität Braunschweig, Institute of Pharmaceutical Technology, Mendelssohnstraße 1, 38106 Braunschweig, Germany.en_GB
dc.identifier.journalJournal of controlled release : official journal of the Controlled Release Societyen_GB

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.